・Expansion culture system of hematopoietic stem cell
・Engineered stem cell
・Non-conditioned stem cell engraftment to in vivo
Abstract
Bone marrow (BM) chimeric mice are a valuable tool in the field of immunology, with the genetic manipulation of donor cells widely used to study gene function under physiological and pathological settings. To date, however, BM chimera protocols require myeloablative conditioning of recipient mice, which dramatically alters steady-state hematopoiesis. Additionally, most protocols use fluorescence-activated cell sorting (FACS) of hematopoietic stem/progenitor cells (HSPCs) for ex vivo genetic manipulation. Here, we describe our development of cell culture techniques for the enrichment of functional HSPCs from mouse BM without the use of FACS purification. Furthermore, the large number of HSPCs derived from these cultures generate BM chimeric mice without irradiation. These HSPC cultures can also be genetically manipulated by viral transduction, to allow for doxycycline-inducible transgene expression in donor-derived immune cells within non-conditioned immunocompetent recipients. This technique is therefore expected to overcome current limitations in mouse transplantation models.
Market Application
This invention provides us an alternative analysis system specialized for hematopoietic cells and immune cell system without making genetically modified mice (KO mouse or Tg mouse) which would reduce the trouble, time, and cost. In addition, this technology would give a better understanding of human immunology and immunotherapy.
Publications
https://www.nature.com/articles/s41467-021-23763-z
Other
https://www.tsukuba.ac.jp/en/research-news/20210611180000.html